logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10457733 B1

PDFFull Text
Date of Patent:
Oct. 29, 2019

Filed:

Aug. 02, 2013

Agents that modulate immune cell activation and methods of use thereof

Applicants:

Dana-farber Cancer Institute, Inc., Boston, MA (US);

Boston Children's Hospital, Boston, MA (US);

President and Fellows of Harvard College, Cambridge, MA (US);

Inventors:

Gordon J. Freeman, Brookline, MA (US);

Arlene H. Sharpe, Brookline, MA (US);

Yanping Xiao, Brookline, MA (US);

Loise Francisco, Belmont, MA (US);

Rosemarie Dekruyff, Newton, MA (US);

Dale Umetsu, Newton, MA (US);

Assignees:

Dana-Farber Cancer Institute, Inc., Boston, MA (US);

President and Fellows of Harvard College, Cambridge, MA (US);

Attorney:

Foley Hoag LLP

Primary Examiner:

Sean E Aeder

Int. Cl.
CPC ...
C07K 16/00 (2006.01); C07K 16/28 (2006.01); G01N 33/50 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); C07K 14/705 (2006.01); G01N 33/68 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2827 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); C07K 14/705 (2013.01); C07K 14/70532 (2013.01); C07K 16/28 (2013.01); G01N 33/5041 (2013.01); G01N 33/5047 (2013.01); G01N 33/6872 (2013.01); A61K 2039/505 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01); C07K 2319/30 (2013.01); G01N 2333/4703 (2013.01); G01N 2333/70596 (2013.01); G01N 2500/02 (2013.01); G01N 2500/10 (2013.01); G01N 2500/20 (2013.01);
Abstract

The present invention relates to compositions and methods for the immunomodulation mediated by the interaction of PD-L2 and RGMb.

Find Patent Forward Citations

Freeman, Gordon. (2019). Agents that modulate immune cell activation and methods of use thereof (U.S. Patent No. 10457733). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10457733

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…